Spectranetics

Spectranetics is a medical technology company based in Colorado that specializes in developing single-use tools for minimally invasive cardiovascular surgeries. The company focuses on lead management, as well as peripheral and coronary interventions, offering advanced products such as scoring balloon technology and laser atherectomy. Spectranetics provides healthcare providers with innovative solutions and proven algorithms to effectively manage cardiac leads, modify plaque, and address complications like restenosis and amputation. With a commitment to product innovation, Spectranetics continually explores new methods to enhance the effectiveness and efficiency of complex cardiovascular procedures, ultimately aiming to improve patient outcomes and quality of life.

Guy Childs

Vice President and CFO

1 past transactions

AngioScore

Acquisition in 2014
AngioScore Inc. is engaged in the development, manufacturing, and marketing of medical devices, specifically focusing on the AngioSculpt Scoring Balloon Catheter. This catheter is designed for use in both coronary and peripheral interventional markets, addressing the limitations commonly associated with traditional angioplasty balloon catheters. The AngioSculpt features a semi-compliant balloon combined with a unique nitinol scoring element, enhancing its effectiveness in endovascular therapy. The company's products are aimed at improving the treatment of cardiovascular and vascular diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.